Vivesto Stock

Vivesto Gross Margin

Gross Margin of Vivesto (VIVE.ST) as of Aug 10, 2026.

Gross Margin

0.00

Last updated:

Gross Margin of Vivesto is 2026 0.00 . Gross Margin of Vivesto was 2025 -10.50 % . It decreases by % higher compared to the previous year.

For Vivesto, the gross margin of -1,049.9% is down versus 13.4% a few years ago.

Access this data via the Eulerpool API

Vivesto Stock analysis

What does Vivesto do? Oasmia Pharmaceutical AB is a Swedish pharmaceutical company that specializes in the development and marketing of innovative cancer and pain medications. The company was founded in 1998 and is headquartered in Uppsala, Sweden. Vivesto is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vivesto stock

On Eulerpool you can find the complete historical development of Gross Margin Vivesto since 2006 – with annual values, charts, and detailed analysis.

Gross Margin measures the percentage of revenue remaining after COGS. Higher gross margins indicate more efficient production and stronger pricing power.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Gross Margin's Vivesto with sector peers and the industry average to assess whether it is attractive.

To evaluate Gross Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Gross Margin.

Access this data via the Eulerpool API

Margins — Vivesto

All Key Metrics — Vivesto